Showing results (191-200 of 529) with videos related to
Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2019
Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic studyJacek Kubica, Piotr Adamski, Katarzyna Buszko, et al.European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribingSeif El Hadidi, Giuseppe Rosano, Juan Tamargo, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2019
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patientsAngelo Silverio, Marco Di Maio, Costantina Prota, et al.European Heart Journal. Cardiovascular Pharmacotherapy|January 11, 2020
The relevance of depressive symptoms for the outcome of patients receiving vitamin K antagonists: results from the thrombEVAL cohort studyMatthias Michal, Lisa Eggebrecht, Sebastian Göbel, et al.European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2020
Effect of ticagrelor monotherapy on mortality after percutaneous coronary intervention: a systematic review and meta-analysis of randomized trials including 26 143 patientsSung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 10, 2019
Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetesSusanne Jung, Agnes Bosch, Dennis Kannenkeril, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 11, 2019
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AFShinichi Goto, Shinya Goto, Karen S Pieper, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 1, 2020
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCIFrancesco Costa, Marco Valgimigli, Philippe Gabriel Steg, et al.European Heart Journal. Cardiovascular Pharmacotherapy|October 29, 2020
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trialsGiuseppe Gargiulo, Christopher P Cannon, Charles Michael Gibson, et al.European Heart Journal. Cardiovascular Pharmacotherapy|October 29, 2020
The burden of cholesterol accumulation through the lifespan: why pharmacological intervention should start earlier to go further?Alberto Zambon, Alberto Mello E Silva, Michel FarnierPageof 53